PedAM
Pediatric Disease Annotations & Medicines
| Disease | vasculitis |
| Symptom | C0019196|hepatitis c |
| Sentences | 17 |
| PubMedID- 24211061 | Central nervous system vasculitis associated with hepatitis c virus infection: a brain mri-supported diagnosis. |
| PubMedID- 23970639 | The two-edged sword: vasculitis associated with hiv and hepatitis c coinfection. |
| PubMedID- 23304615 | The treatment outcomes with rituximab of systemic vasculitis in patients with hepatitis c virus infection with and without detectable mixed cryoglobulinemia have been reported as similar, although in small numbers of patients 7. |
| PubMedID- 26031766 | Cryoglobulinemic vasculitis, not associated with hepatitis c virus (hcv) or lymphoma, can present skin, renal or peripheral nerve involvement. |
| PubMedID- 22020820 | Objective: type ii mixed cryoglobulinemia (mc) is a systemic vasculitis usually associated with hepatitis c virus (hcv). |
| PubMedID- 25380535 | The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis c virus therapy. |
| PubMedID- 23237994 | Rituximab can be used in cryoglobulinemic vasculitis associated with hepatitis c virus infection when antiviral therapy fails or the disease is severe. |
| PubMedID- 23044040 | Objectives: to study the health-related quality of life (hrqol) in severe cryoglobulinaemic vasculitis (cv) associated with hepatitis c virus infection (hcv) and to describe the effect of rituximab on hrqol. |
| PubMedID- 21516850 | An il-6 level in the serum and urine in estimation of cryoglobulinemic vasculitis activity in patients with chronic hepatitis c associated with renal damage. |
| PubMedID- 24787686 | Treatment of cryoglobulinemic vasculitis associated with hepatitis c virus infection. |
| PubMedID- 20952479 | Systemic vasculitis in patients with hepatitis c virus infection with and without detectable mixed cryoglobulinemia. |
| PubMedID- 20338607 | In cryoglobulinemic vasculitis with hepatitis c, the severity of the neuropathy depends on the nature of the cellular inflammation and the size of the vessel involvement. |
| PubMedID- 20981809 | Objective: to analyze the main characteristics and outcome of polyarteritis nodosa (pan)-type vasculitis associated with hepatitis c virus (hcv). |
| PubMedID- 26031898 | Objective: to evaluate whether rituximab at a low dose of 250 mg/m(2) x 2 may be as effective as at higher dosages, most commonly 375 mg/m(2)x4, used in previous studies on the treatment of patients with refractory mixed cryoglobulinemia (mc) vasculitis associated with hepatitis c virus (hcv) infection. |
| PubMedID- 22089995 | By contrast to cryoglobulinemic vasculitis, polyarteritis nodosa associated with hepatitis c virus (hcv) infection is rare and still a controversial entity. |
| PubMedID- 26281206 | The paper presents the steps for studying cryoglobulinemia from essential to cryoglobulinemic vasculitis associated with hepatitis c virus. |
| PubMedID- 26065548 | Leg ulcer as a manifestation of eosinophilic vasculitis in a patient with hepatitis c virus infection, medicated with pegylated interferon/ribavirin. |
Page: 1